Neurocrine Biosciences, Inc. (NBIX)

NASDAQ: NBIX · Real-Time Price · USD

173.00

+2.12 (1.24%)

At close: Jul 20, 2026, 4:00 PM EDT

174.30

+1.30 (0.75%)

After-hours: Jul 20, 2026, 7:34 PM EDT

Neurocrine Biosciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	3,102	2,861	2,355	1,887	1,489	1,134
Revenue Growth (YoY)	28.59%	21.45%	24.81%	26.76%	31.34%	8.38%
Cost of Revenue	56.7	52.1	34	39.7	23.2	14.3
Gross Profit	3,046	2,808	2,321	1,847	1,466	1,119
Selling, General & Admin	1,198	1,156	1,007	887.6	752.7	583.3
Research & Development	1,087	1,033	743.6	708.9	463.8	433.4
Other Operating Expenses	-28.6	-	-	-	-	-
Total Operating Expenses	2,257	2,189	1,751	1,597	1,217	1,017
Operating Income	788.9	619.1	570.5	250.9	249	102.5
Interest Income	96.7	90.3	91	52.8	4.1	3.8
Interest Expense	-	-	-138.4	-	-70	-25.8
Other Non-Operating Income (Expense)	-6.7	-4	-37.1	28.4	30.8	20.9
Total Non-Operating Income (Expense)	148.6	86.3	-84.5	81.2	-35.1	-1.1
Pretax Income	937.5	705.4	486	332.1	213.9	101.4
Provision for Income Taxes	268.9	226.8	144.7	82.4	59.4	11.8
Net Income	668.6	478.6	341.3	249.7	154.5	89.6
Net Income to Common	668.6	478.6	341.3	249.7	154.5	89.6
Net Income Growth	118.64%	40.23%	36.68%	61.62%	72.43%	-78.00%
Shares Outstanding (Basic)	100	100	100	98	96	95
Shares Outstanding (Diluted)	103	103	104	101	99	98
Shares Change (YoY)	-0.73%	-1.16%	2.67%	2.12%	1.02%	0.10%
EPS (Basic)	6.71	4.81	3.40	2.56	1.61	0.95
EPS (Diluted)	6.49	4.67	3.29	2.47	1.56	0.92
EPS Growth	120.00%	41.95%	33.20%	58.33%	69.56%	-77.89%
Free Cash Flow	831.3	748.7	557.2	361.6	322.9	233.1
Free Cash Flow Growth	11.03%	34.37%	54.09%	11.98%	38.52%	7.12%
Free Cash Flow Per Share	8.10	7.30	5.37	3.58	3.26	2.38
Gross Margin	98.17%	98.18%	98.56%	97.90%	98.44%	98.74%
Operating Margin	25.43%	21.64%	24.22%	13.30%	16.73%	9.04%
Profit Margin	21.55%	16.73%	14.49%	13.23%	10.38%	7.90%
FCF Margin	26.80%	26.17%	23.66%	19.16%	21.69%	20.56%
EBITDA	818.7	649.2	597.6	272.2	264.6	113.4
EBITDA Margin	26.39%	22.70%	25.37%	14.42%	17.77%	10.00%
EBIT	788.9	619.1	570.5	250.9	249	102.5
EBIT Margin	25.43%	21.64%	24.22%	13.30%	16.73%	9.04%
Effective Tax Rate	28.68%	32.15%	29.77%	24.81%	27.77%	11.64%

SEC Filings: 10-K · 10-Q